ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Daewoong Pharmaceutical Co. LTD. clinical trials

Part of Daewoong Co., Ltd.

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 224 studies whose lead sponsor is Daewoong Pharmaceutical Co. LTD. or one of 5 companies grouped under it. 35 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 26, 2026.

Our grouping of 6 registry names, not the registry’s. See them and correct one ↓

Compare Daewoong Pharmaceutical with Eli Lilly and Jiangsu HengRui Medicine →

Pipeline: 17 programs

Each counted once: 17 with a study Daewoong Pharmaceutical Co. LTD. leads registered in the last two years.

  • Phase 1
  • Phase 3
  • Phase 4 (approved, new studies)

The 4 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Daewoong Pharmaceutical Co. LTD.’s own registered studies; Daewoong Pharmaceutical Co. LTD.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Daewoong Pharmaceutical Co. LTD.’s studies test, most open studies first — 43 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 43; every drug is on its own page, and each page lists its sponsors.

Coming up

6 of Daewoong Pharmaceutical Co. LTD.’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 2D
  3. J’27
  4. F
  5. 2M
  6. 1A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. 1N

Add all 6 to your calendar (.ics) → With an account.

All 224 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now3516%Recruiting 19 · Not yet recruiting 16
  • Under way, not recruiting125%
  • Completed12355%
  • Stopped early115%Terminated 7 · Withdrawn 3 · Suspended 1
  • Status unknown or other4319%

Phase

Where

  • Korea, Republic of172
  • United States8
  • Indonesia6
  • China4
  • Canada3
  • Australia3

Over the years

  1. 09
  2. 10
  3. 11
  4. 12
  5. 13
  6. 14
  7. 15
  8. 16
  9. 17
  10. 18
  11. 19
  12. 20
  13. 21
  14. 2522
  15. 23
  16. 24
  17. 25
  18. 926

By the year each study started; 1 started before 2009. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Daewoong Pharmaceutical Co. LTD.

  • Daewoong Pharmaceutical Co. LTD.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    200 studies
  • HanAll BioPharma Co., Ltd.
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    16 studies →
  • PT. Daewoong Infion
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • iN Therapeutics Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Daewoong Bio Inc.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Daewoong Group Indonesia
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Daewoong Pharmaceutical Co. LTD. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 224. Browse all 224 →